MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0064243
Keita Pharma Private Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.51 Cr
▲ 55% YoY
Net profit · FY 2025
₹52.86 Lakh
Net margin 6.2%
EBITDA · FY 2025
₹73.42 Lakh
EBITDA margin 8.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹41.09 Lakh
Satisfied ₹2.4 Cr
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
About Keita Pharma Private Limited
Data last updated:
Keita Pharma Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33100MH2010PTC210627. Its GSTIN is 27AAECK1974C1ZN (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dinesh Baliram Gursale and Poonam Dinesh Gursale.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Navi Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.51 Cr, a growth of 55% compared to the previous year. For the same year it recorded a net profit of ₹52.86 Lakh (net margin 6.2%) and EBITDA of ₹73.42 Lakh (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 22% over five years.
The company is associated with 1 brand: Keita Pharma. As per MCA filings, the company has open charges of ₹41.09 Lakh and satisfied charges of ₹2.4 Cr on record.
Keita Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0064243). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website keitapharma.com.
Company details
CIN U33100MH2010PTC210627
Registration Number 210627
Incorporation Date 06 December 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0064243
Recognitions & Rankings of Keita Pharma
Contact details
Keita Pharma Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is keitapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No.B/401 Technocity Plot No.X – 4/1 & X – 4/2 4th Floor MIDC Ttc Industrial Area Maha, Pe, Navi Mumbai, Maharashtra, India – 400710
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Keita Pharma Private Limited, buy the company report.
Comprehensive company report
Keita Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Keita Pharma operates one associated brand: Keita Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacture and export of pharmaceuticals, including injections and nutraceuticals, in India. | keitapharma.com |
Business activity
The main business activity of Keita Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Keita Pharma Private Limited, buy the company report.
Financials of Keita Pharma Private Limited
FY 2025 filings availableKeita Pharma Private Limited reported revenue of ₹8.51 Cr (up 55% YoY) for FY 2025.
Revenue · FY 2025
₹8.51 Cr ▲ 55%
Net profit · FY 2025
₹52.86 Lakh margin 6.2%
EBITDA · FY 2025
₹73.42 Lakh margin 8.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 55%
3 years · compounded
▼ 10%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▲ 33%
3 years · compounded
▲ 31%
5 years · compounded
▲ 12%
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 55% growth in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹73.42 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹52.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.6% | ||||
| Net Profit Margin | 6.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Keita Pharma Private Limited, buy the company report.
Board of directors of Keita Pharma Private Limited
Keita Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinesh Baliram Gursale Also directs: Generic Window Private Limited | Director | 06 Dec 2010 | 15 Years 10 Months | Current |
| Poonam Dinesh Gursale | Director | 10 Aug 2016 | 10 Years 2 Months | Current |
Peer comparison
Keita Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lutim Pharma Private Limited | ₹8.57 Cr (FY 2024) | 6.0% | Dehradun, Uttarakhand, India | |||
| Heal (India) Laboratories Private Limited | ₹8.57 Cr (FY 2025) | 52.0% | Thiruvellor, Tamil Nadu, India | |||
| Keita Pharma Private Limitedthis company | ₹8.51 Cr (FY 2025) | ₹52.86 Lakh | 6.2% | 55.0% | Navi Mumbai, Maharashtra, India | |
| Sudisa Industries Private Limited | ₹8.5 Cr (FY 2025) | 106.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Keita Pharma Private Limited, buy the company report.
Auditor
Keita Pharma Private Limited is audited by DEVANG SHAH & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEVANG SHAH & CO | FY 2022 | 133420W |
Shareholding
The shareholding of Keita Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Keita Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹41.09 Lakh
Satisfied charges
₹2.4 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Aug 2023 | 100783530 | Hdfc Bank Limited | ₹15.09 Lakh | Open | |
| 04 Apr 2022 | 100563882 | Axis Bank Limited | ₹26 Lakh | Open | |
| 16 Sep 2022 | 100615107 | State Bank of India | ₹1 Cr | Satisfied | |
| 31 Mar 2021 | 100456290 | Others | ₹39.9 Lakh | Satisfied | |
| 31 Dec 2020 | 100414750 | Others | ₹1 Cr | Satisfied |
To see the full charge records of Keita Pharma Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Keita Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Keita Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Keita Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECK1974C1ZN | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Keita Pharma Private Limited, buy the company report.
Recent activity
Keita Pharma Private Limited has 3 board changes on record since 2010: 2 appointments and 1 cessation. The latest: Ishwari Devdutt Dhikle ceased to be Director on 28 Jan 2017.
AGM
Keita Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Keita Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 31 Mar 2021 via Charge ID 100456290 with Others was fully satisfied on 08 May 2024.
Charges
A charge registered on 16 Sep 2022 via Charge ID 100615107 with State Bank Of India was fully satisfied on 16 Apr 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15.09 Lakh with Charge ID 100783530 was registered on 24 Aug 2023.
Charges
A charge registered on 31 Dec 2020 via Charge ID 100414750 with Others was fully satisfied on 05 Jan 2023.
Charges
A charge with State Bank Of India amounted to Rs. 100.00 Lakh with Charge ID 100615107 was registered on 16 Sep 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 26.00 Lakh with Charge ID 100563882 was registered on 04 Apr 2022.
Charges
A charge with Others amounted to Rs. 39.90 Lakh with Charge ID 100456290 was registered on 31 Mar 2021.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 100414750 was registered on 31 Dec 2020.
Ceased
Ishwari Devdutt Dhikle ceased to be Director.
Appointed
Poonam Dinesh Gursale was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Keita Pharma is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 December 2010 (16+ years old) and is registered under CIN U33100MH2010PTC210627.
Keita Pharma has 2 current directors:
- Dinesh Baliram Gursale - Director
- Poonam Dinesh Gursale - Director
The latest financial statements of Keita Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Keita Pharma is 27AAECK1974C1ZN, registered in Maharashtra.
The CIN (Corporate Identification Number) of Keita Pharma is U33100MH2010PTC210627. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Keita Pharma was incorporated on 06 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Keita Pharma by revenue are Lutim Pharma Private Limited, Heal (India) Laboratories Private Limited, Sudisa Industries Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ishwari Devdutt Dhikle ceased to be Director on 28 Jan 2017. Poonam Dinesh Gursale was appointed as Director on 10 Aug 2016. Dinesh Baliram Gursale was appointed as Director on 06 Dec 2010.
Yes, Keita Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0064243).
Keita Pharma can be reached through the website keitapharma.com. Its registered office is in Navi Mumbai, Maharashtra, India.
The registered office of Keita Pharma is at Office No.B401 Technocity Plot No.X – 41 & X – 42 4th Floor MIDC Ttc Industrial Area Maha, Pe, Navi Mumbai, Maharashtra, India – 400710.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages